Literature DB >> 28102777

Comparison of early vascular morphological changes between bioresorbable poly-L-lactic acid scaffolds and metallic stents in porcine iliac arteries.

Yasuhito Sekimoto1,2, Hideaki Obara1, Kentaro Matsubara1, Naoki Fujimura1, Hirohisa Harada2, Yuko Kitagawa1.   

Abstract

Bioresorbable scaffolds have the potential to overcome several problems associated with metallic stents. Bioresorbable poly-L-lactic acid (PLLA) scaffold implantation for the treatment of peripheral artery disease has already been reported in animal models and clinical trials; however, no studies comparing PLLA scaffolds and bare metal stents (BMSs) with regard to early vascular morphological changes, identified using intravascular ultrasound (IVUS) analysis, have been reported. In this study, PLLA scaffolds and BMSs were implanted bilaterally in iliac arteries of five miniature pigs. Digital subtraction angiography and IVUS were performed before and immediately after stent implantation and at 6-week follow-up. All PLLA scaffolds and BMSs were patent at 6-week follow-up. Per IVUS analysis, the percent area stenosis did not significantly differ between PLLA scaffolds and BMSs (65.7% vs. 67.2%, P = .761). Furthermore, percent vessel lumen change also did not differ significantly. Neointima formation (the neointimal area plus medial area) was significantly less with PLLA scaffolds than with BMSs (15.65 mm2 vs. 25.69 mm2, P < .001). In conclusion, based on IVUS results, short-term results after stent implantation in porcine iliac arteries were comparable between PLLA scaffolds and BMSs. Therefore, PLLA scaffolds are safe and feasible for implantation in peripheral arteries.

Entities:  

Keywords:  Igaki-Tamai stent; bioresorbable scaffold; intravascular ultrasound; neointima formation; peripheral artery disease; poly-L-lactic acid

Mesh:

Substances:

Year:  2017        PMID: 28102777      PMCID: PMC5465948          DOI: 10.1080/15476278.2017.1280211

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.500


  19 in total

1.  Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments.

Authors:  Salvatore Brugaletta; Bill D Gogas; Hector M Garcia-Garcia; Vasim Farooq; Chrysafios Girasis; Jung Ho Heo; Robert Jan van Geuns; Bernard de Bruyne; Dariuz Dudek; Jacques Koolen; Pieter Smits; Susan Veldhof; Richard Rapoza; Yoshinobu Onuma; John Ormiston; Patrick W Serruys
Journal:  Circ J       Date:  2012-04-24       Impact factor: 2.993

Review 2.  Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.

Authors:  Antonio Curcio; Daniele Torella; Ciro Indolfi
Journal:  Circ J       Date:  2011-04-29       Impact factor: 2.993

Review 3.  Bioresorbable scaffold technologies.

Authors:  Yosinobu Onuma; John Ormiston; Patrick W Serruys
Journal:  Circ J       Date:  2011-02-03       Impact factor: 2.993

4.  Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans.

Authors:  H Tamai; K Igaki; E Kyo; K Kosuga; A Kawashima; S Matsui; H Komori; T Tsuji; S Motohara; H Uehata
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

5.  Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents.

Authors:  Soji Nishio; Kunihiko Kosuga; Keiji Igaki; Masaharu Okada; Eisho Kyo; Takafumi Tsuji; Eiji Takeuchi; Yasutaka Inuzuka; Shinsaku Takeda; Tatsuhiko Hata; Yuzo Takeuchi; Yoshitaka Kawada; Takeshi Harita; Junya Seki; Shunji Akamatsu; Shinichi Hasegawa; Nico Bruining; Salvatore Brugaletta; Sebastiaan de Winter; Takashi Muramatsu; Yoshinobu Onuma; Patrick W Serruys; Shigeru Ikeguchi
Journal:  Circulation       Date:  2012-04-16       Impact factor: 29.690

6.  Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study.

Authors:  Ilkka Uurto; Joonas Mikkonen; Jyrki Parkkinen; Leo Keski-Nisula; Timo Nevalainen; Minna Kellomäki; Pertti Törmälä; Juha-Pekka Salenius
Journal:  J Endovasc Ther       Date:  2005-06       Impact factor: 3.487

7.  Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

Authors:  Bo Lagerqvist; Stefan K James; Ulf Stenestrand; Johan Lindbäck; Tage Nilsson; Lars Wallentin
Journal:  N Engl J Med       Date:  2007-02-12       Impact factor: 91.245

8.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.

Authors:  R Kornowski; M K Hong; F O Tio; O Bramwell; H Wu; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

9.  Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study.

Authors:  Martin Werner; Antonio Micari; Angelo Cioppa; Giuseppe Vadalà; Andrej Schmidt; Horst Sievert; Paolo Rubino; Annalisa Angelini; Dierk Scheinert; Giancarlo Biamino
Journal:  JACC Cardiovasc Interv       Date:  2014-02-13       Impact factor: 11.195

10.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

Authors:  Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.